Jalra-DP Tablet is a combination medicine used for the management of type 2 diabetes. It contains vildagliptin, which increases insulin production from the pancreas, and dapagliflozin, which helps the kidneys remove excess sugar through urine. This dual mechanism targets blood sugar control from two different pathways.
This treatment helps stabilise blood sugar levels throughout the day and reduces the risk of long-term damage to the nerves and blood vessels. It is particularly useful for people who need more than one active medicine to reach their blood sugar targets.
Stay well hydrated to support kidney function and reduce the chance of urinary infections while taking this medicine.
Consult your doctor for regular monitoring of your kidney function and blood sugar levels while on this therapy.






































































